Published in PLoS One on December 10, 2012
Spectral discrimination of breast pathologies in situ using spatial frequency domain imaging. Breast Cancer Res (2013) 1.16
System analysis of spatial frequency domain imaging for quantitative mapping of surgically resected breast tissues. J Biomed Opt (2013) 1.03
Optical spectral surveillance of breast tissue landscapes for detection of residual disease in breast tumor margins. PLoS One (2013) 1.03
A diffuse reflectance spectral imaging system for tumor margin assessment using custom annular photodiode arrays. Biomed Opt Express (2012) 0.93
Rapid intraoperative visualization of breast lesions with γ-glutamyl hydroxymethyl rhodamine green. Sci Rep (2015) 0.92
Towards non-invasive characterization of breast cancer and cancer metabolism with diffuse optics. PET Clin (2013) 0.81
A Quantitative Diffuse Reflectance Imaging (QDRI) System for Comprehensive Surveillance of the Morphological Landscape in Breast Tumor Margins. PLoS One (2015) 0.81
Quantitative molecular phenotyping with topically applied SERS nanoparticles for intraoperative guidance of breast cancer lumpectomy. Sci Rep (2016) 0.80
Characterizing optical properties and spatial heterogeneity of human ovarian tissue using spatial frequency domain imaging. J Biomed Opt (2016) 0.78
Assessing Absorption Coefficient of Hemoglobin in the Breast Phantom Using Near-Infrared Spectroscopy. Iran J Radiol (2016) 0.75
Using DRS during breast conserving surgery: identifying robust optical parameters and influence of inter-patient variation. Biomed Opt Express (2016) 0.75
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 24.57
Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg (2002) 3.43
Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast. Radiology (2001) 3.41
Variability in reexcision following breast conservation surgery. JAMA (2012) 3.26
Monte Carlo-based inverse model for calculating tissue optical properties. Part I: Theory and validation on synthetic phantoms. Appl Opt (2006) 3.17
Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence. Ann Surg Oncol (2007) 3.04
Diagnosing breast cancer by using Raman spectroscopy. Proc Natl Acad Sci U S A (2005) 2.95
Noninvasive functional optical spectroscopy of human breast tissue. Proc Natl Acad Sci U S A (2001) 2.88
Sources of absorption and scattering contrast for near-infrared optical mammography. Acad Radiol (2001) 2.66
Intraoperative evaluation of breast tumor margins with optical coherence tomography. Cancer Res (2009) 2.28
The relationship between shaved margin and inked margin status in breast excision specimens. Cancer (1997) 2.22
Characterization of hemoglobin, water, and NIR scattering in breast tissue: analysis of intersubject variability and menstrual cycle changes. J Biomed Opt (2004) 2.17
In vivo margin assessment during partial mastectomy breast surgery using raman spectroscopy. Cancer Res (2006) 2.12
Diagnosis of breast cancer using elastic-scattering spectroscopy: preliminary clinical results. J Biomed Opt (2000) 2.09
Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions. Ann Surg Oncol (2009) 2.02
Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol (2007) 1.92
Diagnosing breast cancer using diffuse reflectance spectroscopy and intrinsic fluorescence spectroscopy. J Biomed Opt (2008) 1.81
Positive margins: the challenge continues for breast surgeons. Ann Surg Oncol (2008) 1.77
The role of frozen section analysis of margins during breast conservation surgery. Cancer J Sci Am (1997) 1.69
Accuracy of intraoperative gross examination of surgical margin status in women undergoing partial mastectomy for breast malignancy. Am Surg (2005) 1.65
Monte Carlo-based inverse model for calculating tissue optical properties. Part II: Application to breast cancer diagnosis. Appl Opt (2006) 1.64
Accuracy of intraoperative frozen-section analysis of breast cancer lumpectomy-bed margins. J Am Coll Surg (2005) 1.57
Bulk optical properties and tissue components in the female breast from multiwavelength time-resolved optical mammography. J Biomed Opt (2004) 1.55
Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys (1998) 1.49
Quantitative optical spectroscopy: a robust tool for direct measurement of breast cancer vascular oxygenation and total hemoglobin content in vivo. Cancer Res (2009) 1.47
Diagnosis of breast cancer using diffuse reflectance spectroscopy: Comparison of a Monte Carlo versus partial least squares analysis based feature extraction technique. Lasers Surg Med (2006) 1.46
Performance metrics of an optical spectral imaging system for intra-operative assessment of breast tumor margins. Opt Express (2010) 1.43
Computational methods for analysis of human breast tumor tissue in optical coherence tomography images. J Biomed Opt (2006) 1.42
Comparison of multiexcitation fluorescence and diffuse reflectance spectroscopy for the diagnosis of breast cancer (March 2003). IEEE Trans Biomed Eng (2003) 1.35
Diagnosing breast cancer using Raman spectroscopy: prospective analysis. J Biomed Opt (2009) 1.34
Benign and malignant lesions in the human breast depicted with ultrahigh resolution and three-dimensional optical coherence tomography. Radiology (2007) 1.34
Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery. Am J Surg (2003) 1.33
Rapid noninvasive optical imaging of tissue composition in breast tumor margins. Am J Surg (2009) 1.33
Use of a multiseparation fiber optic probe for the optical diagnosis of breast cancer. J Biomed Opt (2005) 1.28
Touch preparation cytology of breast lumpectomy margins with histologic correlation. Arch Surg (1991) 1.27
Diagnosis of breast cancer using fluorescence and diffuse reflectance spectroscopy: a Monte-Carlo-model-based approach. J Biomed Opt (2008) 1.26
A robust Monte Carlo model for the extraction of biological absorption and scattering in vivo. IEEE Trans Biomed Eng (2009) 1.24
Autofluorescence and diffuse reflectance spectroscopy and spectral imaging for breast surgical margin analysis. Lasers Surg Med (2010) 1.22
The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery. Am J Surg (2006) 1.22
Autofluorescence and diffuse reflectance properties of malignant and benign breast tissues. Ann Surg Oncol (2004) 1.19
Use of touch preps for diagnosis and evaluation of surgical margins in breast cancer. Ann Surg Oncol (1998) 1.18
Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center. Breast J (2009) 1.14
Intraoperative evaluation of lumpectomy margins by imprint cytology with histologic correlation: a community hospital experience. Arch Pathol Lab Med (2002) 1.12
Optical assessment of tumor resection margins in the breast. IEEE J Sel Top Quantum Electron (2010) 1.10
Measurement of optical transport properties of normal and malignant human breast tissue. Appl Opt (2001) 1.10
Influence of breast cancer margin assessment method on the rates of positive margins and residual carcinoma. Am J Surg (2006) 1.09
Optical breast cancer margin assessment: an observational study of the effects of tissue heterogeneity on optical contrast. Breast Cancer Res (2010) 1.08
The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat (2010) 1.07
Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy? Ann Surg Oncol (2007) 1.07
Comparison of autofluorescence, diffuse reflectance, and Raman spectroscopy for breast tissue discrimination. J Biomed Opt (2008) 1.04
Impact of routine cavity shave margins on breast cancer re-excision rates. Ann Surg Oncol (2010) 1.03
Spatially offset Raman spectroscopy of layered soft tissues. Opt Lett (2009) 1.03
Diagnosis of breast cancer using diffuse optical spectroscopy from 500 to 1600 nm: comparison of classification methods. J Biomed Opt (2011) 1.02
Breast conservation surgery achieving>or=2 mm tumor-free margins results in decreased local-regional recurrence rates. Breast J (2006) 1.02
Automated classification of breast pathology using local measures of broadband reflectance. J Biomed Opt (2011) 0.99
Factors associated with re-excision in patients with early-stage breast cancer treated with breast conservation therapy. Am Surg (2010) 0.97
Model based and empirical spectral analysis for the diagnosis of breast cancer. Opt Express (2008) 0.92
Pathologic Assessment of Surgical Margins on Frozen and Permanent Sections in Breast Conserving Surgery. Breast Cancer (1995) 0.91
Determinants of positive histologic margins and residual tumor after lumpectomy for early breast cancer: a prospective study with special reference to touch preparation cytology. J Surg Oncol (1997) 0.91
Is frozen section analysis of reexcision lumpectomy margins worthwhile? Margin analysis in breast reexcisions. Cancer (1994) 0.88
Advances in optical spectroscopy and imaging of breast lesions. J Mammary Gland Biol Neoplasia (2006) 0.88
Breast conserving surgery: optimizing local control in the breast with the assessment of margins. Breast Dis (2001) 0.78
Quantitative comparison of surgical margin histology following excision with traditional electrosurgery and a low-thermal-injury dissection device. J Surg Oncol (2011) 0.76
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA (2006) 24.01
Epidemiology of basal-like breast cancer. Breast Cancer Res Treat (2007) 7.08
27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science (2013) 3.52
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA (2013) 3.38
A pathway-based classification of human breast cancer. Proc Natl Acad Sci U S A (2010) 3.30
Retracted Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA (2008) 3.26
Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res (2010) 3.04
Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies. Am J Pathol (2005) 2.05
Simulating association studies: a data-based resampling method for candidate regions or whole genome scans. Bioinformatics (2007) 1.77
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med (2015) 1.76
Genomic strategy for targeting therapy in castration-resistant prostate cancer. J Clin Oncol (2009) 1.75
A review of effective methods of delivery of care: skill-mix and service transfer to primary care settings. Prim Dent Care (2010) 1.69
Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression. Hum Pathol (2007) 1.65
Heading down the wrong pathway: on the influence of correlation within gene sets. BMC Genomics (2010) 1.59
High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype. Mod Pathol (2005) 1.57
Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infection. Am J Pathol (2006) 1.53
Public knowledge of and attitudes toward genetics and genetic testing. Genet Test Mol Biomarkers (2013) 1.52
Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles. Sci Transl Med (2014) 1.50
Quantitative optical spectroscopy: a robust tool for direct measurement of breast cancer vascular oxygenation and total hemoglobin content in vivo. Cancer Res (2009) 1.47
Retracted An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer. PLoS One (2008) 1.45
Performance metrics of an optical spectral imaging system for intra-operative assessment of breast tumor margins. Opt Express (2010) 1.43
Greater percent-free testosterone is associated with high-grade prostate cancer in men undergoing prostate biopsy. Urology (2012) 1.43
Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg (2005) 1.39
Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. Cancer Res (2002) 1.38
Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer. Breast Cancer Res Treat (2007) 1.35
Identification of novel cellular targets in biliary tract cancers using global gene expression technology. Am J Pathol (2003) 1.33
Rapid noninvasive optical imaging of tissue composition in breast tumor margins. Am J Surg (2009) 1.33
hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands. Mol Cancer (2007) 1.33
Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status. Cancer Res (2010) 1.28
Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. Mod Pathol (2003) 1.28
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians. J Clin Oncol (2010) 1.27
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer. J Natl Cancer Inst (2010) 1.26
Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresias. J Allergy Clin Immunol (2013) 1.25
A robust Monte Carlo model for the extraction of biological absorption and scattering in vivo. IEEE Trans Biomed Eng (2009) 1.24
Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene (2005) 1.23
Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome. J Clin Oncol (2010) 1.20
Statistical challenges in preprocessing in microarray experiments in cancer. Clin Cancer Res (2008) 1.19
HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites. Breast Cancer Res Treat (2003) 1.19
Global expression analysis of well-differentiated pancreatic endocrine neoplasms using oligonucleotide microarrays. Clin Cancer Res (2003) 1.18
The oncotype DX recurrence score is correlated with a composite index including routinely reported pathobiologic features. Cancer Invest (2010) 1.18
Intraoperative imprint cytology and frozen section pathology for margin assessment in breast conservation surgery: a systematic review. Ann Surg Oncol (2012) 1.17
Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance). Ann Surg (2015) 1.15
The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study. Breast Cancer Res (2005) 1.14
Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues. Am J Pathol (2002) 1.13
Consensus Report: 2nd European Workshop on Tobacco Use Prevention and Cessation for Oral Health Professionals. Int Dent J (2010) 1.12
Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass. AJR Am J Roentgenol (2003) 1.12
p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis. Am J Surg Pathol (2003) 1.12
Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines. Breast Cancer Res Treat (2011) 1.12
Dental skill mix: a cross-sectional analysis of delegation practices between dental and dental hygiene-therapy students involved in team training in the South of England. Hum Resour Health (2014) 1.11
Optical assessment of tumor resection margins in the breast. IEEE J Sel Top Quantum Electron (2010) 1.10
Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer. Breast Cancer Res (2012) 1.09
Epidermal growth factor receptor expression correlates with histologic grade in resected esophageal adenocarcinoma. J Gastrointest Surg (2004) 1.08
Optical breast cancer margin assessment: an observational study of the effects of tissue heterogeneity on optical contrast. Breast Cancer Res (2010) 1.08
Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF. Clin Cancer Res (2007) 1.05
A network of substrates of the E3 ubiquitin ligases MDM2 and HUWE1 control apoptosis independently of p53. Sci Signal (2013) 1.04
Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer. BMC Cancer (2006) 1.03
Optical spectral surveillance of breast tissue landscapes for detection of residual disease in breast tumor margins. PLoS One (2013) 1.03
Quantitative optical spectroscopy can identify long-term local tumor control in irradiated murine head and neck xenografts. J Biomed Opt (2009) 1.03
αB-crystallin: a novel regulator of breast cancer metastasis to the brain. Clin Cancer Res (2013) 1.02
Akt expression may predict favorable prognosis in cholangiocarcinoma. J Gastroenterol Hepatol (2006) 1.02
Optimization of a widefield structured illumination microscope for non-destructive assessment and quantification of nuclear features in tumor margins of a primary mouse model of sarcoma. PLoS One (2013) 1.01
Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer. Ann Surg (2016) 1.01
Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells. Gynecol Oncol (2011) 1.01
Empirical pathway analysis, without permutation. Biostatistics (2013) 1.00
Use of the out-of-hours emergency dental service at two south-east London hospitals. BMC Oral Health (2009) 1.00
Statistical considerations for analysis of microarray experiments. Clin Transl Sci (2011) 1.00
Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors. Clin Cancer Res (2005) 1.00
Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy. Cancer Prev Res (Phila) (2013) 0.99
CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis. Cancer Epidemiol Biomarkers Prev (2009) 0.99
DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival. Breast Cancer Res (2014) 0.98
A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia. Clin Cancer Res (2009) 0.98
Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation. Oncogene (2005) 0.97
Using optical spectroscopy to longitudinally monitor physiological changes within solid tumors. Neoplasia (2009) 0.96